Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
- Status
- TERMINATED
- Phase
- PHASE2
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease
- Status
- COMPLETED
- Phase
- N/A
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
- Status
- COMPLETED
- Phase
- PHASE4
Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
- Status
- UNKNOWN
- Phase
- N/A
Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization
- Status
- COMPLETED
- Phase
- N/A
Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease
- Status
- UNKNOWN
- Phase
- NA
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
- Status
- COMPLETED
- Phase
- N/A
Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE2
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE3
Proton Beam Therapy for Treatment of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC
- Status
- UNKNOWN
- Phase
- NA